Antibióticos

<p>Neomycin B is an aminoglycoside antibiotic, which is derived from the bacterium *Streptomyces fradiae*. It exerts its antibacterial effects by binding to the 30S subunit of bacterial ribosomes, leading to the inhibition of protein synthesis. This binding disrupts the translation process, thereby preventing the growth and proliferation of bacteria. Neomycin B is effective against a wide range of Gram-negative and some Gram-positive bacteria, making it a valuable tool in both medical and research settings.</p>

<p>Sulbenicillin is a semi-synthetic penicillin antibiotic, which is derived from 6-aminopenicillanic acid, a natural precursor in the biosynthesis of penicillins. With its beta-lactam structure, Sulbenicillin disrupts bacterial cell wall synthesis by inhibiting penicillin-binding proteins, which are essential enzymes in the cross-linking of peptidoglycan layers. This disruption compromises the structural integrity of the bacterial cell wall, resulting in cell lysis and death, particularly in Gram-negative bacteria.</p>

<p>Inhibitor of protein synthesis; lincosamide class</p>

<p>Sarecycline is a tetracycline-class antibiotic, which is derived from naturally occurring tetracycline antibiotics. Its mode of action involves inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the addition of amino acids to nascent peptide chains. This specific mechanism disrupts bacterial growth, making Sarecycline effective against certain strains of bacteria implicated in dermatological conditions.</p>

<p>Cloxacillin benzathine is a beta-lactam antibiotic, which is synthesized from Penicillium fungi-derived penicillins. It acts by inhibiting bacterial cell wall synthesis. The mechanism involves the irreversible inhibition of penicillin-binding proteins (PBPs). This disruption in the bacterial cell wall structure ultimately leads to cell lysis and death.</p>

<p>Ceftizoxime alapivoxil is a prodrug antibiotic, which is derived from ceftizoxime, a third-generation cephalosporin. This semi-synthetic source enables the compound to effectively combat a wide range of bacterial infections by improving oral bioavailability compared to its parent compound. Once administered, ceftizoxime alapivoxil is metabolized in the body to release ceftizoxime, which exerts its antibacterial activity by binding to penicillin-binding proteins (PBPs) on bacterial cell walls. This binding action inhibits the transpeptidation step critical for cell wall synthesis, leading to cell lysis and bacterial death.</p>

<p>8-Fluoro erythromycin is a synthetic derivative of the macrolide antibiotic erythromycin. It is derived from the fermentation of *Streptomyces erythraeus*, a species known for producing erythromycin, which is chemically modified to include a fluorine atom at the eighth position. This modification enhances its pharmacokinetic properties, improving its stability and bioavailability compared to the parent compound.</p>

<p>Potassium clavulanate is a beta-lactamase inhibitor and an antibacterial agent. The presence of potassium clavulanate in culture media inhibits the activity of beta-lactamases, which are enzymes that confer resistance to penicillin and other beta-lactam antibiotics. It also has been shown to be active against bacterial infections such as tuberculosis, sepsis, and pneumonia, where it can inhibit the growth of bacteria by interfering with their ability to form cell walls.</p>

<p>Vancomycin CDP-1 is a degradation product of vancomycin with no direct therapeutic action but used in research for analytical method development and validation.</p>

<p>2'-O-Acetylspiramycin I is a semi-synthetic derivative of spiramycin, which is a macrolide antibiotic originally sourced from the bacterium *Streptomyces ambofaciens*. The modification involves the acetylation at the 2'-hydroxyl group of spiramycin, enhancing certain pharmacokinetic properties.</p>

<p>25-O-Deacetyl rifabutin is an antibiotic derivative, which is sourced from the semi-synthetic modification of rifabutin, a compound originally derived from the fermentation of the bacterium Amycolatopsis mediterranei. This derivative works by inhibiting bacterial RNA synthesis. It achieves this by specifically targeting the DNA-dependent RNA polymerase enzyme, which is essential for bacterial transcription. The mechanism involves binding to the beta-subunit of the polymerase, thereby blocking the elongation of the RNA chain, which ultimately leads to the death of the bacterial cell.</p>

<p>Dihydrostreptomycin sesquisulfate is an aminoglycoside antibiotic, which is derived from the bacterium Streptomyces griseus. Its mode of action involves binding to the 30S subunit of the bacterial ribosome, leading to the disruption of protein synthesis. This binding interferes with the initiation complex formation, causing misreading of mRNA and ultimately inhibiting bacterial growth.</p>

<p>Mitomycin C analogue</p>

<p>Thiostrepton is a thiopeptide antibiotic with action on bacterial protein synthesis by binding to the ribosome and is used for treating bacterial infections in veterinary medicine and research applications.</p>

<p>N-Demethyl rifampin is a metabolite of rifampin, which is a natural product derivative. Rifampin itself is a well-known antibiotic derived from the bacterium *Amycolatopsis rifamycinica*. N-Demethyl rifampin is formed through the metabolic process where rifampin undergoes demethylation. This transformation occurs primarily in the liver, mediated by the cytochrome P450 enzyme system.</p>

<p>Trovafloxacin mesylate is a synthetic antibiotic belonging to the fluoroquinolone class, which is derived from chemical synthesis processes rather than natural sources. The mode of action of trovafloxacin mesylate involves the inhibition of bacterial enzymes DNA gyrase and topoisomerase IV. These enzymes are essential for DNA replication, repair, and transcription within the bacterial cell. By inhibiting these enzymes, trovafloxacin mesylate disrupts bacterial DNA processes, leading to cell death and exerting its antibacterial effects.</p>

<p>N-Desisobutyl-N-propyl rifabutin is a synthetic derivative of rifabutin, which is an antibiotic belonging to the rifamycin class. This compound is sourced from modifications of the parent molecule rifabutin, itself derived from the rifamycin family produced by the bacterium Amycolatopsis, traditionally used for its antimicrobial properties. The mode of action involves the inhibition of bacterial RNA polymerase, effectively preventing the transcription process necessary for bacterial replication and protein synthesis. This disruption of RNA synthesis provides potent antimicrobial activity.</p>

<p>Tri-O-benzyl FR 900098 is a chemical compound, often referenced in biochemical research contexts. It is a synthetic derivative that originates from complex chemical synthesis, involving multiple benzylation steps to modify the original molecular framework. This structural transformation lends the compound unique chemical properties.</p>

<p>(E)-10,11-Didehydro-11-deoxy-6-O-methylerythromycin is a semisynthetic macrolide antibiotic, which is derived from erythromycin, a natural product obtained from the bacterium *Saccharopolyspora erythraea*. This compound functions as an inhibitor of protein synthesis by binding to the 50S ribosomal subunit of bacteria, thus preventing the growth and proliferation of susceptible bacterial strains. The alteration in its chemical structure, notably the methylation at the 6-O position, enhances its stability and improves its pharmacokinetic profile compared to the parent compound, erythromycin.</p>

<p>Cefoxitin EP impurity B is a chemical reference standard, which is derived from the synthesis and purification processes involved in producing Cefoxitin. As an impurity standard, its primary role is to serve as a benchmark for quality control in pharmaceutical formulations. The mode of action of Cefoxitin EP impurity B involves the structural analysis and quantification of impurity levels, ensuring that the primary pharmaceutical products meet necessary safety and efficacy criteria.</p>

<p>Clindamycin 4-phosphate is a semi-synthetic antibiotic, which is a derivative of the natural antibiotic lincomycin. It is specifically synthesized from Streptomyces lincolnensis cultures. The mode of action of Clindamycin 4-phosphate involves inhibiting bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome, thus preventing peptide chain elongation and subsequent bacterial growth.</p>

<p>Tetracycline hydrochloride is a broad-spectrum antibiotic and is an electron transfer agent. It has been shown to be effective against bacterial infections in humans and has been used in cultures for the prevention of bacterial contamination. As an electron transfer agent, it is used in electron microscopy to study the surface of biological cells. Tetracycline hydrochloride enters bacterial cells by diffusion and interacts with the cytoplasmic membrane, where it induces a redox reaction that leads to cell death. The efficacy of tetracycline hydrochloride in treating candida albicans (yeast) was studied using in-vitro activity and showed that carboxymethyl chitosan nanoparticles were able to enhance the treatment efficiency.</p>

<p>Antibacterial agent with the ability to permeate bacterial membranes and cause cell death. Colistin is a cationic peptide also known as polymyxin E. Colistin is effective in multidrug resistant Gram-positive bacteria such as P. aeruginosa, A. baumannii and K. pneumoniae.</p>

<p>Oligomycin B is an antibiotic compound, which is derived from Streptomyces species. It is an inhibitor of the mitochondrial ATP synthase complex, specifically targeting the F₀ subunit of ATP synthase. This action obstructs the proton channel, preventing the flow of protons across the mitochondrial membrane. As a result, Oligomycin B effectively halts ATP synthesis by oxidative phosphorylation, which is crucial for the survival of aerobic organisms.</p>

<p>7-epi-Clindamycin is a clindamycin derivative, which is a semisynthetic antibiotic derived from the bacterium *Streptomyces lincolnensis*. Its mode of action involves binding to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis. This results in the suppression of bacterial growth, making it effective against certain Gram-positive bacteria and anaerobic species.</p>

<p>Lysostaphin, from Staphylococcus staphylolyticus is a zinc metalloenzyme with action on bacterial cell walls by cleaving polyglycine cross-links and is used for treating staphylococcal infections and in research applications.</p>

<p>Cefotaxime sodium - Sterile grade is a cephalosporin antibiotic, which is derived from the beta-lactam class of antibacterial agents. It effectively disrupts bacterial cell wall synthesis by binding to and inhibiting penicillin-binding proteins, leading to cell lysis and death. This mechanism of action is potent against a variety of Gram-positive and Gram-negative bacteria, making it a valuable tool in clinical settings.</p>

<p>Clarithromycin-13CD3 is an isotopically labeled macrolide antibiotic, which is synthesized to include deuterium (D) and carbon-13 (^13C) in its molecular structure. This modified compound serves as a stable isotope-labeled standard, primarily sourced from chemical synthesis. The incorporation of these isotopes differentiates it from the naturally occurring antibiotic, enabling its use in precise analytical studies.</p>

<p>Vincristine, a microtubule disruptor, inhibits mitosis in cancer cells, useful in leukemia research.</p>

<p>Peplomycin sulfate is an anticancer antibiotic, which is a derivative of the bleomycin family of glycopeptide antibiotics produced by the bacterium *Streptomyces verticillus*. This antibiotic operates through a mode of action that involves the induction of DNA strand breaks by forming a complex with iron and oxygen, leading to the generation of free radicals. These radicals cleave DNA strands, thereby inhibiting DNA synthesis and inducing apoptosis in cancerous cells.</p>

<p>Telavancin is a lipoglycopeptide antibiotic, which is a semi-synthetic derivative of vancomycin. Its source is derived through modifications of the glycopeptide antibiotic, specifically aimed to enhance antibacterial activity. Telavancin functions by inhibiting cell wall synthesis in Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It does this by binding to the D-alanyl-D-alanine terminus of cell wall precursors, disrupting peptidoglycan polymerization and, consequently, cell wall integrity. Additionally, Telavancin increases membrane permeability and disrupts membrane potential, further enhancing its bactericidal activity.</p>

<p>1,3''-Di-HABA kanamycin A is a chemically modified antibiotic derivative. It is derived from kanamycin A, a well-known aminoglycoside antibiotic that is originally sourced from the bacterium *Streptomyces kanamyceticus*. The modification with 1,3''-Di-HABA alters its pharmacodynamic properties, potentially influencing its specificity and interaction with biological targets.</p>

<p>Erythromycylamine is a semisynthetic antibiotic, which is derived from the parent compound erythromycin. This compound is sourced from the fermentation product of the bacterium *Saccharopolyspora erythraea*. Erythromycylamine acts by inhibiting bacterial protein synthesis, specifically targeting the 50S ribosomal subunit, which ultimately leads to the disruption of bacterial cell growth and replication.</p>

<p>N'-Desmethyl azithromycin is a semi-synthetic derivative antibiotic, which is derived from the chemical modification of azithromycin, a macrolide antibiotic sourced originally from the bacterium *Streptomyces erythreus*. It functions primarily by inhibiting bacterial protein synthesis, binding specifically to the 50S ribosomal subunit, which results in the prevention of transpeptidation and translocation processes during translation. This action effectively halts bacterial growth, rendering it bacteriostatic.</p>

<p>Erythromycin derivative</p>

<p>Tyrothricin is a peptide antibiotic, which is derived from the bacterium Bacillus brevis. This compound comprises a mixture of polypeptides, primarily gramicidin and tyrocidine, both of which are instrumental in its antimicrobial activity. The mode of action of tyrothricin involves disrupting bacterial cell membranes, leading to cell lysis and death. Gramicidin increases the permeability of the bacterial membrane to ions, while tyrocidine promotes disruption of membrane integrity, which together exert bactericidal and bacteriostatic effects.</p>

<p>Dequalinium chloride is a novel, broad spectrum antimicrobial agent with a mechanism of action that inhibits the mitochondria-dependent respiratory chain. Studies have shown that it inhibits the growth of resistant microorganisms in cell-based experiments and in bacterial infections. Dequalinium chloride also has cytopathic effects on thp-1 cells, which are specific for Mycobacterium tuberculosis. In addition to inhibiting mitochondria-dependent respiration, this compound also increases acetylcholine receptor sensitivity in A549 lung cancer cells. Dequalinium chloride is a quaternary ammonium cation and has been shown to be effective against clinical isolates and inhibitory concentrations of a variety of virus species, including human rhinovirus (HRV) and Coxsackie virus type B4 (CoxB4).</p>

<p>Fosmidomycin sodium is an antibiotic compound, which is derived from phosphonic acid. It functions as an inhibitor of the enzyme 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR), crucial in the non-mevalonate pathway of isoprenoid biosynthesis. By targeting this enzyme, fosmidomycin sodium disrupts the production of isoprenoids, essential components for the growth and survival of certain bacteria and parasites.</p>

<p>Gentamicin C2 pentaacetate (2 : 1 Mixture of C2 and C2a) is an aminoglycoside class antibiotic derivative, primarily derived from the fermentation of Micromonospora species. This product is a semi-synthetic compound, combining two closely related gentamicin components, C2 and C2a, in a specified ratio. Its mode of action involves binding to the 30S subunit of the bacterial ribosome, which disrupts protein synthesis resulting in bactericidal activity against a wide spectrum of Gram-negative and some Gram-positive bacteria.</p>

<p>11-Deoxyfusidic acid is a steroidal antibiotic, which is derived from the fermentation broth of certain strains of fungi, specifically within the Fusidium genus. Its mode of action involves inhibiting bacterial protein synthesis by interacting with elongation factor G (EF-G) on the ribosome, thus disrupting essential processes and impeding bacterial growth.</p>

<p>Inducer of apoptosis; translational inhibitor; aminonucleoside antibiotic</p>

<p>Panipenem is a carbapenem antibiotic, which is a type of beta-lactam antibiotic derived from thienamycin. It functions by inhibiting penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis. This inhibition disrupts the cell wall construction, leading to cell lysis and death, thereby demonstrating strong bactericidal activity.</p>

<p>3'-N-Desmethyl-3'-N-tosyl azithromycin is a semi-synthetic macrolide antibiotic analog, which is a derivative of azithromycin, a well-known member of the macrolide class of antibiotics. This compound is synthesized through chemical modifications of the parent molecule, azithromycin, to potentially enhance its pharmacokinetic and pharmacodynamic properties.</p>

<p>7-O-Demethyl rapamycin is a macrolide compound, which is a derivative of rapamycin, originally sourced from the bacterial species *Streptomyces hygroscopicus*. This compound operates by binding to the FK506-binding protein 12 (FKBP12), forming a complex that inhibits the mammalian target of rapamycin (mTOR) pathway. This inhibition interferes with cellular processes such as cell growth, proliferation, and survival by altering the phosphorylation state of downstream targets.</p>

<p>Inhibitor of protein synthesis; streptogramin</p>

<p>Chlortetracycline is a tetracycline antibiotic, which is derived from the bacterium *Streptomyces aureofaciens*. It functions by inhibiting protein synthesis through binding to the 30S ribosomal subunit, thereby preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This mechanism effectively impedes the growth and replication of both gram-positive and gram-negative bacteria.</p>

<p>3'-N-Desmethyl-3'-N-formyl azithromycin is a semi-synthetic macrolide antibiotic, derived from the well-known azithromycin. It is created through structural modification, where the 3'-N-demethylated and 3'-N-formyl groups enhance its pharmacokinetic properties and potentially improve its antimicrobial efficacy.</p>

<p>Streptidine dihydrochloride is a biochemical compound, specifically a derivative of streptomycin, which is obtained through chemical modification of the aminoglycoside antibiotic streptomycin. It is composed of streptidine, a constituent sugar derivative, that is integral to the structure of streptomycin, rendered as a hydrochloride salt to enhance solubility and stability.</p>

<p>Herbimycin is an antibiotic, which is a natural product derived from Streptomyces bacteria. It functions primarily as a tyrosine kinase inhibitor, disrupting cellular signaling pathways by binding to the ATP-binding site of kinases and inhibiting phosphorylation events. This mode of action makes it an effective tool for scientists studying signal transduction processes and oncogenic transformation.</p>

<p>4-Epitetracycline hydrochloride is a tetracycline antibiotic derivative, which is a secondary metabolite derived from bacterial sources, particularly Streptomyces species. It functions primarily by inhibiting protein synthesis in bacteria through binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA to the RNA-ribosome complex. This action hinders bacterial growth by interfering with vital processes necessary for bacterial survival and replication.</p>

<p>(+)-Madindoline A is a chemical substance that inhibits the growth of cancer cells. It has been shown to inhibit colon cancer cell proliferation and induce apoptosis by inhibiting signal pathways and suppressing inflammatory responses. (+)-Madindoline A is an experimental model for the study of bowel disease and inflammatory diseases, as it can be used to treat both bowel disease and inflammatory diseases. It also has inhibitory effects on the production of proinflammatory cytokines in human protein cells and natural compounds in experimental models. (+)-Madindoline A is found in small amounts in food compositions such as apples, carrots, cauliflower, celery, cucumbers, garlic, leeks, lettuce, onions, peas, peppers, potatoes and tomatoes.</p>

<p>Iclaprim is an antibiotic, which is a synthetic diaminopyrimidine antimicrobial agent with a specific mechanism of action. It works by selectively inhibiting bacterial dihydrofolate reductase, a crucial enzyme in the bacterial folate synthesis pathway. This inhibition prevents the production of tetrahydrofolate, ultimately disrupting DNA, RNA, and protein synthesis in susceptible bacterial cells.</p>

<p>Dicloxacillin sodium salt monohydrate is a beta-lactam antibiotic with action on bacterial cell wall synthesis and is used for treating infections caused by penicillinase-producing bacteria.</p>

<p>Pirlimycin HCl is an antibacterial product, which is a semi-synthetic derivative of the natural antibiotic lincomycin produced by Streptomyces lincolnensis. Its mode of action involves the inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the elongation of peptide chains. This action is particularly effective against Gram-positive bacteria, including Staphylococcus and Streptococcus species.</p>

<p>Piperacillin oxalylamide is an investigational antibiotic, which is a synthetic derivative of the widely used β-lactam antibiotic, piperacillin. Its development is rooted in the quest to combat β-lactamase-producing resistant bacterial strains, which are a growing threat in clinical settings. It operates by inhibiting bacterial cell wall synthesis, similar to other β-lactam antibiotics, but possesses a modified structure that enhances its resistance to enzymatic degradation by β-lactamases.</p>

<p>L-Carnitine fumarate is a compound that functions as a dietary supplement, which is synthesized by combining L-carnitine, an amino acid derivative naturally found in the body, with fumaric acid. This product is primarily sourced from fermentation or chemical synthesis processes to produce L-carnitine, which is then reacted with fumaric acid to form the fumarate salt. This combination enhances the stability and bioavailability of L-carnitine.</p>

<p>Sulfadiazine-d4 is an isotopically labeled antibiotic, which is a derivative of sulfadiazine containing four deuterium atoms. This compound is synthesized using advanced chemical techniques to replace hydrogen atoms with deuterium in the molecular structure. The mechanism of action involves inhibition of bacterial dihydropteroate synthase, an enzyme critical in the folate synthesis pathway. By preventing the production of folic acid, sulfadiazine-d4 effectively halts bacterial growth and replication.</p>

<p>Hypothemycin is a natural product that serves as a potent inhibitor of protein kinases. It is derived from the fungus Hypomyces subiculosus and belongs to the class of resorcylic acid lactones. Its mode of action involves binding covalently to the ATP-binding site of kinases, leading to the inhibition of their activity. This covalent modification is achieved through the formation of a Michael-type addition with a reactive ene-diene functionality within its structure. By targeting these critical enzymes, hypothemycin disrupts key signaling pathways that are essential for cell growth and proliferation.</p>

<p>Cefquinome is a broad-spectrum antibiotic, which is a fourth-generation cephalosporin. It is derived from the β-lactam class of antibiotics and is specifically designed for veterinary applications. Its mode of action involves the inhibition of bacterial cell wall synthesis, leading to cell lysis and death. This action is facilitated through the binding of cefquinome to penicillin-binding proteins, which undermines the structural integrity of bacterial cell walls, proving effective against both Gram-positive and Gram-negative bacteria.</p>

<p>Alamethacin is a peptide antibiotic, which is derived from the soil fungus Trichoderma viride. This compound consists of a sequence of amino acids that form a helical structure, enabling its interaction with lipid membranes. Alamethacin functions by inserting itself into cellular membranes and forming voltage-dependent ion channels. As a result, it alters membrane permeability, causing ion imbalance and leading to cell death.</p>

<p>Ascomycin is an immunosuppressant macrolide lactone, which is derived from the soil bacterium *Streptomyces hygroscopicus*. It functions primarily by inhibiting the T-cell activation pathway. The mechanism involves binding to the immunophilin FKBP-12, forming a complex that inhibits the calcium-dependent phosphatase, calcineurin. This inhibition prevents the dephosphorylation and subsequent translocation of nuclear factor of activated T cells (NFAT), which is crucial for the transcription of interleukin-2 and other cytokines. Consequently, this suppresses the activation and proliferation of T-cells, which are essential components of the adaptive immune response.</p>

<p>Aphidicolin is a tetracyclic diterpenoid that acts as a potent inhibitor of DNA polymerase. Derived from the fungus *Cephalosporium aphidicola*, it is primarily identified for its ability to impede DNA synthesis by targeting eukaryotic DNA polymerase α. This selective inhibition disrupts replication processes, making it a crucial tool for studying cell cycle dynamics.</p>

<p>6,11-Di-O-methyl erythromycin is a semi-synthetic derivative of erythromycin, which is a macrolide antibiotic originally sourced from the bacterium *Saccharopolyspora erythraea*. This compound is produced through chemical modification of the natural antibiotic to improve its pharmacokinetic properties, such as stability and absorption.</p>

<p>Cefquinome sulfate is a cephalosporin antibiotic, which is a synthetic, broad-spectrum antimicrobial agent. It is derived from the beta-lactam family, specifically designed to combat Gram-positive and Gram-negative bacterial pathogens. The mode of action involves inhibiting bacterial cell wall synthesis. It achieves this by binding to penicillin-binding proteins (PBPs) within the bacterial cell wall, ultimately leading to cell lysis and death due to the interruption of necessary cell wall components.</p>

<p>Doxycycline is an antibiotic that inhibits bacterial growth by inhibiting protein synthesis, respiratory chain, DNA gyrase, DNA topoisomerase IV. Doxycycline inhibits papaverine by blocking the expression of both cytochrome P450 and epoxide hydrolase. Doxycycline is commonly found in studies for bacterial infections, drug therapy, histopathological studies, cell culture and chemometric analysis.</p>

<p>Anhydro erythromycin A is a semi-synthetic derivative of erythromycin A, which has been shown to be an effective inhibitor of bacterial growth, showing higher selectivity for this inhibition. It is a prodrug that is activated by acid catalysis and can be used as a substitute against methicillin-resistant staphylococcus. Anhydro erythromycin A was developed with the goal of increasing its stability and its potency against methicillin-resistant Staphylococcus aureus, which has been shown to be resistant to erythromycin.</p>

<p>Dicloxacillin is a penicillin antibiotic that is used to treat bacterial infections of the gastrointestinal tract, skin, and urinary tract. It binds to the penicillin-binding proteins in bacterial cell walls by competitive inhibition. Dicloxacillin inhibits bacterial growth by binding to the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. Dicloxacillin sodium salt is available as tablets for oral administration or as an intravenous solution for injection. It can interact with other drugs, such as benzalkonium chloride and matrix effect; it also has analytical methods such as chromatographic analysis and rate constant.</p>

<p>14-Chloro daunorubicin is a chemotherapeutic agent, which is a synthetic derivative of the naturally occurring anthracycline antibiotic, daunorubicin. This compound is specifically modified to include a chlorine atom at the 14th position, which enhances its pharmacological effectiveness compared to its parent compound. The drug acts primarily by intercalating into DNA, disrupting the function of topoisomerase II, and generating free radicals. These mechanisms collectively inhibit DNA replication and transcription, leading to cell apoptosis, particularly in rapidly dividing cancer cells.</p>

<p>Erythromycin derivative</p>

<p>Cefotiam is a broad-spectrum cephalosporin antibiotic, which is a beta-lactam compound derived from the mold Acremonium. It functions by inhibiting bacterial cell wall synthesis, particularly by targeting penicillin-binding proteins, which leads to cell lysis and death in susceptible bacteria. This mechanism of action makes it effective against various Gram-positive and Gram-negative bacteria.</p>

<p>Ceftobiprole medocaril is a prodrug of the cephalosporin class, which is a beta-lactam antibiotic. It is synthetically derived, designed to combat Gram-positive and Gram-negative bacteria. The mode of action involves binding to penicillin-binding proteins (PBPs), crucial for bacterial cell wall synthesis, ultimately leading to bacterial cell lysis and death.</p>

<p>Inhibitor of protein synthesis; lincosamide</p>

<p>Inhibitor of protein synthesis; aminoglycoside</p>

<p>Erythromycin lactobionate is a macrolide antibiotic, which is derived from the bacterium *Saccharopolyspora erythraea*. Its mode of action involves binding to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to the suppression of bacterial growth. This mechanism effectively targets gram-positive bacteria and some gram-negative bacteria, making it a crucial agent in the fight against various bacterial infections.</p>

<p>Tropodithietic acid is a bioactive compound, which is a potent antibacterial agent derived from certain marine bacteria, including the genus Phaeobacter. This antibiotic is characterized by its ability to disrupt quorum sensing, a mechanism that bacteria use for communication and coordination of group behaviors, including virulence. By interfering with this process, tropodithietic acid impedes bacterial colonization and biofilm formation, effectively inhibiting pathogenic activity.</p>

<p>Nafcillin sodium monohydrate is a beta-lactam antibiotic, which is derived from the penicillin class of antimicrobials. It is specifically a semi-synthetic penicillin and is commonly sourced through chemical synthesis to enhance its stability and spectrum of activity. Nafcillin primarily exerts its bactericidal effects by inhibiting bacterial cell wall synthesis. It achieves this through its strong affinity for penicillin-binding proteins (PBPs), which are essential for maintaining the bacterial cell wall structure. By disrupting the formation of peptidoglycan cross-links, nafcillin effectively weakens the bacterial cell wall, leading to cell lysis and death, especially in gram-positive bacteria such as Staphylococcus aureus, including methicillin-sensitive strains (MSSA).</p>

<p>Clindamycin-2,4-diphosphate is a phosphorylated derivative of the antibiotic clindamycin, which is a semi-synthetic lincosamide antibiotic originally derived from Streptomyces lincolnensis. Its mode of action involves the inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing peptide chain elongation during translation. This mechanism effectively disrupts protein production in susceptible bacteria, leading to their growth inhibition or death.</p>

<p>Norvancomycin trifluoroacetate is an antibiotic compound, which is a glycopeptide derived from the bacterium Amycolatopsis orientalis. Its mode of action involves inhibiting bacterial cell wall synthesis. Specifically, Norvancomycin disrupts the cross-linking of peptidoglycan layers in the bacterial cell wall by binding to the D-alanyl-D-alanine terminus of cell wall precursors. This disruption weakens the bacterial cell wall, ultimately leading to cell lysis and death, thereby exerting a bactericidal effect.</p>

<p>Finafloxacin is a fluoroquinolone antibacterial agent, which is a synthetic compound derived from the quinolone family. It functions through the inhibition of bacterial DNA gyrase and topoisomerase IV, crucial enzymes in the replication, transcription, and repair of bacterial DNA. This mechanism leads to the prevention of bacterial cell division and ultimately results in cell death.</p>

<p>Pazufloxacin is an antibacterial agent, which is a synthetic derivative originating from the fluoroquinolone class of compounds. This source categorizes it alongside a group of broad-spectrum antibiotics known for their efficacy against a wide variety of bacterial pathogens. The mode of action of pazufloxacin involves the inhibition of bacterial DNA gyrase and topoisomerase IV. These are essential enzymes for bacterial DNA replication, transcription, repair, and recombination processes. By inhibiting these enzymes, pazufloxacin disrupts the bacterial DNA processes, ultimately leading to cell death.</p>

<p>Cephamycin C is a cephalosporin antibiotic, which is a type of β-lactam antibiotic. It is derived from the fermentation process of certain Streptomyces species and other actinomycetes. Its mode of action involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This inhibition disrupts the structural integrity of the bacterial cell wall, leading to cell lysis and death.</p>

<p>Nigericin transports cations across the membrane of the cell and it is used to study anion transport. It can be used as a buffer to control pH value inside of the cell.</p>

<p>3'-N,N-Di(desmethyl)-3'-N-formyl azithromycin is a semisynthetic macrolide antibiotic derivative, which is synthesized through chemical modification of azithromycin. Azithromycin is originally derived from erythromycin, which is produced by the bacterium Saccharopolyspora erythraea. The modifications in this derivative result in enhanced specificity and altered pharmacokinetic properties compared to the parent compound.</p>

<p>Plant growth regulator</p>